Skin Cancer News and Research

Latest Skin Cancer News and Research

Dundee Centre to help set the pace for national and international progress in cancer research

Dundee today (Thursday) becomes Scotland's first link in a unique chain of Cancer Research UK Centres that are being launched across the UK. The launch of the Dundee Centre coincides with World Cancer Day.

4 Feb 2010

BRAF drugs may accelerate tumour growth in cancer patients with faulty RAS gene

A team of UK scientists has made the unexpected discovery that drugs which target a well known fault in a protein called BRAF could actually fuel the progression of cancer in some cases. The findings of this study, which was jointly funded by Cancer Research UK, The Institute of Cancer Research (ICR) and the Wellcome Trust are published in Cell.

3 Feb 2010

Phase III study evaluating PEP005 Gel for treatment of AK meets primary clinical endpoint

LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.

2 Feb 2010

Discovery may help in designing drugs for sun-damaged skin

Researchers at Ohio State University have found a new way to study how enzymes move as they repair DNA sun damage -- and that discovery could one day lead to new therapies for healing sunburned skin.

29 Jan 2010

Level of key immune cells in kidney transplant patients may predict risk of skin cancer

Measuring certain types of immune cells may predict the high risk of skin cancer after kidney transplantation, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

29 Jan 2010

Indoor tanning: FTC prohibits ITA from making false health and safety claims

The American Academy of Dermatology (Academy) applauds the Federal Trade Commission (FTC) for issuing a consent order that prohibits the Indoor Tanning Association (ITA) from making false health and safety claims about indoor tanning. The Academy raised its concerns about the false statements being made by the ITA with the FTC in 2008 after the ITA launched an advertising campaign designed to portray indoor tanning as safe and beneficial.

28 Jan 2010

People with higher levels of vitamin D less likely to develop bowel cancer

People with higher levels of vitamin D appear to be significantly less likely to develop bowel cancer, a new European study has found.

27 Jan 2010

CDA to host skin cancer awareness event at Winnipeg

Winnipeg dermatologists are inviting members of the public to a skin cancer awareness event at Polo Park Shopping Centre's Community Centre, Winnipeg, on Monday January 25, 2010, from 10 am to 1.30 pm.

22 Jan 2010

Cancer Research UK welcomes government's decision to ban sunbeds

Cancer Research UK welcomes the government's intention to ban the use of sunbeds by under-18s following the launch of a Private Member's Bill in Parliament by Julie Morgan, MP for Cardiff North.

18 Jan 2010

freshHAIR: A new hair care line to prevent acne

Renee Cobos, MD, a board certified dermatologist and associate professor of dermatology at the University of California, Irvine, announced the launch of RC freshHAIR™, the first dermatologist-created hair care line that is specifically formulated to treat and prevent acne, acne rosacea, seborrhea (dandruff) and oily skin. RC freshHAIR is the newest addition to the RC Dermatology™ line of skin care products.

18 Jan 2010

New class of drugs could help prevent skin cancer

A new study by Loyola University Health System researchers could lead to alternative treatments that would shrink skin cancer tumors with drugs. The drugs would work by turning on a gene that prevents skin cells from becoming cancerous, said senior author Mitchell Denning, Ph.D.

18 Jan 2010

Research reveals how cancers shield themselves from immune attack

Melanoma, if not detected in its early stages, transforms into a highly deadly, treatment-resistant cancer. Although the immune system initially responds to melanoma and mounts anti-tumor attacks, these assaults are generally ineffective, allowing more advanced melanomas to win the battle and spread beyond the primary site.

13 Jan 2010

Abraxis Bioscience awards John Wayne Cancer Institute $1M grant for identifying new cancer biomarkers

A $1 million grant from Abraxis Bioscience, Inc. to a world-famous research laboratory at John Wayne Cancer Institute at Saint John’s Health Center could help save lives of cancer patients by helping doctors more rapidly assess whether a treatment is working or not.

12 Jan 2010

Evidence-based care for lung cancer patients results in an average cost savings of 35%, says study

A study recently conducted by US Oncology and Aetna finds that evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes. The study, which compared patients treated with evidence-based guidelines (also known as ‘on pathway’) to those treated with non-evidence-based guidelines (also known as ‘off pathway’), was published in the peer-reviewed Journal of Oncology Practice.

12 Jan 2010

Plexxikon commences dosing in PLX4032 Phase 3 trial for metastatic melanoma

Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 “BRAF Inhibitor in Melanoma” (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.

9 Jan 2010

King Center to host second annual 'Health and Wellness Forum'

The King Center announced that it will officially launch the 2010 MLK Birthday Observance on Saturday, Jan. 9, 2010 by hosting and co-sponsoring its second annual “Health and Wellness Forum.” It is being co-sponsored by a $50,000 grant from Aetna, which also funded last year’s inaugural program.

8 Jan 2010

Pfizer and Debiopharm Group enter into co-development agreement to conduct Phase 3 trial of tremelimumab

Pfizer Inc. (Pfizer) and Debiopharm Group™ (Debiopharm) announced today that they have entered into a co-development agreement to conduct a Phase 3 trial of tremelimumab (CP675,206), a fully human anti-CTLA4 monoclonal antibody for the treatment of patients with unresectable, Stage IV melanoma.

8 Jan 2010

Similar effectiveness in treatment options for low-risk prostate cancer; research may help improve patient outcomes

A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably.

6 Jan 2010

ASTRO: Sexual function does not decline in prostate cancer patients receiving EBRT

Sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first two years after treatment but then stabilizes and does not continuously decline as was previously thought, according to a study in the January 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

6 Jan 2010

Health Canada approves Zyclara Cream for multiple actinic keratoses

Health Canada has approved Zyclara™ (imiquimod) Cream 3.75%, a topical prescription treatment for multiple actinic keratoses (AK) located on the face or balding scalp in adults. Actinic Keratosis is a common skin condition that can lead to squamous cell carcinoma, a form of non-melanoma skin cancer, if left untreated.

6 Jan 2010

Skin Cancer News and Research

Latest Skin Cancer News and Research

Dundee Centre to help set the pace for national and international progress in cancer research

BRAF drugs may accelerate tumour growth in cancer patients with faulty RAS gene

Phase III study evaluating PEP005 Gel for treatment of AK meets primary clinical endpoint

Discovery may help in designing drugs for sun-damaged skin

Level of key immune cells in kidney transplant patients may predict risk of skin cancer

Indoor tanning: FTC prohibits ITA from making false health and safety claims

People with higher levels of vitamin D less likely to develop bowel cancer

CDA to host skin cancer awareness event at Winnipeg

Cancer Research UK welcomes government's decision to ban sunbeds

freshHAIR: A new hair care line to prevent acne

New class of drugs could help prevent skin cancer

Research reveals how cancers shield themselves from immune attack

Abraxis Bioscience awards John Wayne Cancer Institute $1M grant for identifying new cancer biomarkers

Evidence-based care for lung cancer patients results in an average cost savings of 35%, says study

Plexxikon commences dosing in PLX4032 Phase 3 trial for metastatic melanoma

King Center to host second annual 'Health and Wellness Forum'

Pfizer and Debiopharm Group enter into co-development agreement to conduct Phase 3 trial of tremelimumab

Similar effectiveness in treatment options for low-risk prostate cancer; research may help improve patient outcomes

ASTRO: Sexual function does not decline in prostate cancer patients receiving EBRT

Health Canada approves Zyclara Cream for multiple actinic keratoses

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Skin Cancer News and Research

Latest Skin Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in